195 related articles for article (PubMed ID: 27473135)
21. Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy.
Resnick SM; Espeland MA; An Y; Maki PM; Coker LH; Jackson R; Stefanick ML; Wallace R; Rapp SR;
J Clin Endocrinol Metab; 2009 Nov; 94(11):4152-61. PubMed ID: 19850684
[TBL] [Abstract][Full Text] [Related]
22. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
Manson JE; Chlebowski RT; Stefanick ML; Aragaki AK; Rossouw JE; Prentice RL; Anderson G; Howard BV; Thomson CA; LaCroix AZ; Wactawski-Wende J; Jackson RD; Limacher M; Margolis KL; Wassertheil-Smoller S; Beresford SA; Cauley JA; Eaton CB; Gass M; Hsia J; Johnson KC; Kooperberg C; Kuller LH; Lewis CE; Liu S; Martin LW; Ockene JK; O'Sullivan MJ; Powell LH; Simon MS; Van Horn L; Vitolins MZ; Wallace RB
JAMA; 2013 Oct; 310(13):1353-68. PubMed ID: 24084921
[TBL] [Abstract][Full Text] [Related]
23. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis.
Henderson VW; St John JA; Hodis HN; McCleary CA; Stanczyk FZ; Shoupe D; Kono N; Dustin L; Allayee H; Mack WJ
Neurology; 2016 Aug; 87(7):699-708. PubMed ID: 27421538
[TBL] [Abstract][Full Text] [Related]
24. Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease.
Jiang X; Nudy M; Aragaki AK; Robbins JA; Manson JE; Stefanick ML; OʼSullivan DM; Shikany JM; LeBlanc ES; Kelsey AM; Cauley J; Martin LW; Payne ME; Johnson KC; Howard B; Schnatz PF
Menopause; 2019 Aug; 26(8):841-849. PubMed ID: 31145202
[TBL] [Abstract][Full Text] [Related]
25. Cardiometabolic outcomes in Kronos Early Estrogen Prevention Study continuation: 14-year follow-up of a hormone therapy trial.
Kantarci K; Tosakulwong N; Lesnick TG; Kara F; Kendall-Thomas J; Kapoor E; Fields JA; James TT; Lobo RA; Manson JE; Pal L; Hammers DB; Malek-Ahmadi M; Cedars MI; Naftolin FN; Santoro N; Miller VM; Harman SM; Dowling NM; Gleason CE
Menopause; 2024 Jan; 31(1):10-17. PubMed ID: 37989141
[TBL] [Abstract][Full Text] [Related]
26. Effect of hormone replacement therapy on lipids in perimenopausal and early postmenopausal women.
Ossewaarde ME; Bots ML; Bak AA; Van Der Schouw YT; Witteman JC; Planellas J; Bennink HJ; Grobbee DE
Maturitas; 2001 Sep; 39(3):209-16. PubMed ID: 11574180
[TBL] [Abstract][Full Text] [Related]
27. Effects of combination estrogen plus progestin hormone treatment on cognition and affect.
Resnick SM; Maki PM; Rapp SR; Espeland MA; Brunner R; Coker LH; Granek IA; Hogan P; Ockene JK; Shumaker SA;
J Clin Endocrinol Metab; 2006 May; 91(5):1802-10. PubMed ID: 16522699
[TBL] [Abstract][Full Text] [Related]
28. Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
Kling JM; Dowling NM; Bimonte-Nelson H; Gleason CE; Kantarci K; Stonnington CM; Harman SM; Naftolin F; Pal L; Cedars M; Manson JE; James TT; Brinton EA; Miller VM
Maturitas; 2023 Jan; 167():113-122. PubMed ID: 36395695
[TBL] [Abstract][Full Text] [Related]
29. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
[TBL] [Abstract][Full Text] [Related]
30. Effects of estrogen with and without progestin on urinary incontinence.
Hendrix SL; Cochrane BB; Nygaard IE; Handa VL; Barnabei VM; Iglesia C; Aragaki A; Naughton MJ; Wallace RB; McNeeley SG
JAMA; 2005 Feb; 293(8):935-48. PubMed ID: 15728164
[TBL] [Abstract][Full Text] [Related]
31. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
32. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
[TBL] [Abstract][Full Text] [Related]
33. Brain volumes, cognitive impairment, and conjugated equine estrogens.
Espeland MA; Tindle HA; Bushnell CA; Jaramillo SA; Kuller LH; Margolis KL; Mysiw WJ; Maldjian JA; Melhem ER; Resnick SM;
J Gerontol A Biol Sci Med Sci; 2009 Dec; 64(12):1243-50. PubMed ID: 19729392
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the symptomatic response in Indian menopausal women with different estrogen preparations for the treatment of menopausal symptoms: a randomized controlled trial.
Malik S; Pannu D; Prateek S; Sinha R; Gaikwad H
Arch Gynecol Obstet; 2016 Jun; 293(6):1325-33. PubMed ID: 26884352
[TBL] [Abstract][Full Text] [Related]
35. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.
Harman SM; Black DM; Naftolin F; Brinton EA; Budoff MJ; Cedars MI; Hopkins PN; Lobo RA; Manson JE; Merriam GR; Miller VM; Neal-Perry G; Santoro N; Taylor HS; Vittinghoff E; Yan M; Hodis HN
Ann Intern Med; 2014 Aug; 161(4):249-60. PubMed ID: 25069991
[TBL] [Abstract][Full Text] [Related]
36. The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women.
Barrett-Connor E; Slone S; Greendale G; Kritz-Silverstein D; Espeland M; Johnson SR; Waclawiw M; Fineberg SE
Maturitas; 1997 Jul; 27(3):261-74. PubMed ID: 9288699
[TBL] [Abstract][Full Text] [Related]
37. Effect of short-term estrogen therapy on endothelial function: a double-blinded, randomized, controlled trial.
Hurtado R; Celani M; Geber S
Climacteric; 2016 Oct; 19(5):448-51. PubMed ID: 27427235
[TBL] [Abstract][Full Text] [Related]
38. Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.
Decensi A; Omodei U; Robertson C; Bonanni B; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Mora S; Sandri MT; Cazzaniga M; Franchi M; Pecorelli S
Circulation; 2002 Sep; 106(10):1224-8. PubMed ID: 12208797
[TBL] [Abstract][Full Text] [Related]
39. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
[TBL] [Abstract][Full Text] [Related]
40. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Kurabayashi M
Atherosclerosis; 2006 Dec; 189(2):436-42. PubMed ID: 16469323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
